Detection of prion infection in variant Creutzfeldt-Jakob disease: a blood-based assay.
about
Quantum dots and prion proteins: is this a new challenge for neurodegenerative diseases imaging?All clinically-relevant blood components transmit prion disease following a single blood transfusion: a sheep model of vCJDPreclinical detection of variant CJD and BSE prions in blood.Role of magnetic resonance imaging, cerebrospinal fluid, and electroencephalogram in diagnosis of sporadic Creutzfeldt-Jakob disease.Advanced tests for early and accurate diagnosis of Creutzfeldt-Jakob disease.Distribution and Quantitative Estimates of Variant Creutzfeldt-Jakob Disease Prions in Tissues of Clinical and Asymptomatic PatientsA simple, versatile and sensitive cell-based assay for prions from various speciesPostmortem findings in a case of variant Creutzfeldt-Jakob disease treated with intraventricular pentosan polysulfate.White blood cell-based detection of asymptomatic scrapie infection by ex vivo assaysAccelerated, spleen-based titration of variant Creutzfeldt-Jakob disease infectivity in transgenic mice expressing human prion protein with sensitivity comparable to that of survival time bioassay.Diagnostic accuracy of cerebrospinal fluid protein markers for sporadic Creutzfeldt-Jakob disease in Canada: a 6-year prospective study.Variant Creutzfeldt-Jakob disease with extremely low lymphoreticular deposition of prion protein.Population screening for variant Creutzfeldt-Jakob disease using a novel blood test: diagnostic accuracy and feasibility study.Altered Prion protein expression pattern in CSF as a biomarker for Creutzfeldt-Jakob disease.Detection of prion protein particles in blood plasma of scrapie infected sheep.Searching for reliable premortem protein biomarkers for prion diseases: progress and challenges to date.First demonstration of transmissible spongiform encephalopathy-associated prion protein (PrPTSE) in extracellular vesicles from plasma of mice infected with mouse-adapted variant Creutzfeldt-Jakob disease by in vitro amplification.Variant CJD. 18 years of research and surveillance.The molecular epidemiology of variant CJD.Plasminogen-based capture combined with amplification technology for the detection of PrP(TSE) in the pre-clinical phase of infectionPrion disease blood test using immunoprecipitation and improved quaking-induced conversionThe development of surface-enhanced Raman scattering as a detection modality for portable in vitro diagnostics: progress and challenges.Red-backed vole brain promotes highly efficient in vitro amplification of abnormal prion protein from macaque and human brains infected with variant Creutzfeldt-Jakob disease agent.In vitro detection of prionemia in TSE-infected cervids and hamsters.Estimation of the exposure of the UK population to the bovine spongiform encephalopathy agent through dietary intake during the period 1980 to 1996.Recent US Case of Variant Creutzfeldt-Jakob Disease-Global Implications.Mechanism of scrapie prion precipitation with phosphotungstate anions.Efficacy of humidity retention bags for the reduced adsorption and improved cleaning of tissue proteins including prion-associated amyloid to surgical stainless steel surfaces.Prionemia and leukocyte-platelet-associated infectivity in sheep transmissible spongiform encephalopathy models.Could immunomodulation be used to prevent prion diseases?Salivary prions in sheep and deerTransmission of Soluble and Insoluble α-Synuclein to Mice.Preclinical detection of infectivity and disease-specific PrP in blood throughout the incubation period of prion diseaseFast and ultrasensitive method for quantitating prion infectivity titre.Aryl Diazonium Chemistry for the Surface Functionalization of Glassy BiosensorsIdentification of misfolded proteins in body fluids for the diagnosis of prion diseases.Ethics in prion disease.Quantitative EEG parameters correlate with the progression of human prion diseases.Highly infectious prions generated by a single round of microplate-based protein misfolding cyclic amplification.Laboratory activities involving transmissible spongiform encephalopathy causing agents: risk assessment and biosafety recommendations in Belgium.
P2860
Q27008857-F384FE62-DBB1-4900-AFAB-FEAF5A79AB3FQ27324879-455C8267-2F2C-4445-B138-236045027A0EQ30436588-3EAEEDA9-7A82-45B8-A803-CDBC973FFEDEQ30539712-164EADB3-DE2B-40B7-9E08-EB57BADA18D7Q31095751-53457066-D7F3-4C66-B056-612AC004DC78Q33724583-7BD474E8-C105-420A-85AC-42488C61DA0DQ33926922-5B39D230-7892-45B1-B2D1-633540558EF5Q33956775-A340B7C5-B6AA-4138-8E32-93C345E6A00FQ34046572-845E26E7-5CF0-4DA7-9C7C-00B00C5023B1Q34057924-8B6F744B-D78D-45AD-9D2F-6C43006A06D9Q34059789-13183BD5-8901-49A9-AAF7-53E7BCD624F9Q34153667-D253E055-17B8-4E73-99A1-E17D519E6274Q34153674-9FDD4A06-3258-4970-ABBF-97309D95A4BEQ34257239-F3EBE013-F7B0-4BB8-89C4-B320235F7EAFQ34261862-4FACA31A-BC1B-4AEC-B648-2A08DBE918F5Q34342895-FFEAFDE3-771C-42FB-A660-6DE880F4992BQ34355775-8303A017-E581-46AA-85AC-A0D8D3CB7266Q34453109-B8910854-C544-4116-B867-74E016A07F8CQ34632274-618C98A4-28AF-4F80-A05E-D0613D750AE9Q34874108-C07A6BC5-2F8A-4D64-B694-B48A67F4BD8EQ35006294-97251D23-6471-406E-A807-F2B21663ABF0Q35029838-6245B982-6B22-4211-9FD4-AD320A639849Q35036649-34A55107-CB96-4EC1-8986-D5791F20DEB4Q35041621-7940494E-0F82-4832-BCC0-FE0B93AD5E06Q35148934-8C9AB50C-6E0C-4DAB-98CC-60601264C7B5Q35546137-A3F809E9-3079-4B93-A0D3-28F32A67DA89Q35624254-0AA8A526-35DD-405B-8769-38DBDBA6E2BAQ35742977-9BA5B80F-191C-4DAD-B0A0-BB99E5051769Q35826534-486CCC41-C871-416A-9EE2-95720E7275DBQ35875915-7E20962E-71DE-48FD-9FDD-FEE3D3F0F476Q35918937-44DD6D80-21E7-459F-AF16-9D54196186C1Q36303655-A6BF4C7C-5367-410A-98DD-0751297D0D00Q36343836-B90DC0F8-2DCB-4876-AD02-F32E0C887856Q36456289-8DAD7B8C-186D-437A-8E21-883D667BA713Q36736021-9EB3709E-1530-4414-879E-8BAEA028B73EQ37147766-27524A49-94B5-47DF-BAA9-299E0F42AC6CQ37282279-D8E5C5BA-A304-4CA2-9450-4E761FDAEE2EQ37282473-9FD64EA9-A815-41C1-A73D-AFD92A721D05Q37446459-265577B1-AD81-4391-8390-038754F87A6AQ37523329-392CD414-79AD-4830-8E2A-0C5D2E8244EC
P2860
Detection of prion infection in variant Creutzfeldt-Jakob disease: a blood-based assay.
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Detection of prion infection in variant Creutzfeldt-Jakob disease: a blood-based assay.
@ast
Detection of prion infection in variant Creutzfeldt-Jakob disease: a blood-based assay.
@en
Detection of prion infection in variant Creutzfeldt-Jakob disease: a blood-based assay.
@nl
type
label
Detection of prion infection in variant Creutzfeldt-Jakob disease: a blood-based assay.
@ast
Detection of prion infection in variant Creutzfeldt-Jakob disease: a blood-based assay.
@en
Detection of prion infection in variant Creutzfeldt-Jakob disease: a blood-based assay.
@nl
prefLabel
Detection of prion infection in variant Creutzfeldt-Jakob disease: a blood-based assay.
@ast
Detection of prion infection in variant Creutzfeldt-Jakob disease: a blood-based assay.
@en
Detection of prion infection in variant Creutzfeldt-Jakob disease: a blood-based assay.
@nl
P2093
P1433
P1476
Detection of prion infection in variant Creutzfeldt-Jakob disease: a blood-based assay.
@en
P2093
Anita Sicilia
Graham S Jackson
Jessica Lowe
John Collinge
Jonathan Beck
Julie Ann Edgeworth
Michael Farmer
Paul Tavares
Peter Rudge
Simon Mead
P304
P356
10.1016/S0140-6736(10)62308-2
P407
P577
2011-02-01T00:00:00Z